Related Experiment Video

Updated: Aug 23, 2026

Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay
10:14

Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay

Published on: September 2, 2014

[Effect of arsenic trioxide on telomerase and telomerase reverse transcriptase in KM3 cell line]

Zhen-Xing Guo1, Jie Jin

  • 1Department of Hematology, The First Affiliated Hospital, Medical College of Zhejiang University, Hangzhou 310003, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|July 2, 2004
PubMed

Insights

Arsenic trioxide inhibits multiple myeloma (MM) cell growth and induces apoptosis by arresting the cell cycle and down-regulating telomerase activity and hTERT expression. This suggests a key role for telomerase in MM cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Multiple myeloma (MM) is a cancer of plasma cells.
  • Understanding the mechanisms of anti-cancer agents is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the effects of arsenic trioxide on the KM(3) multiple myeloma cell line.
  • To elucidate the underlying mechanisms of arsenic trioxide's action, focusing on apoptosis and telomerase activity.

Main Methods:

  • Cell viability assessed by trypan-blue exclusion.
  • Apoptosis detected via morphology and DNA ladder assays.
  • Cell cycle analysis performed using flow cytometry (FCM).
  • Telomerase activity measured by TRAP-RT-PCR-ELISA.
  • hTERT mRNA expression quantified by RT-PCR.

Main Results:

  • Arsenic trioxide significantly inhibited KM(3) cell growth and viability.
  • Induction of apoptosis and G2 phase cell cycle arrest observed.
  • Significant inhibition of telomerase activity correlated with decreased hTERT mRNA expression.

Conclusions:

  • Arsenic trioxide effectively reduces multiple myeloma cell viability and promotes apoptosis.
  • Down-regulation of telomerase activity and hTERT expression is a key mechanism.
  • These findings highlight the therapeutic potential of arsenic trioxide in multiple myeloma.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration09:24

In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration

Published on: February 23, 2019

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...